SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-042010
Filing Date
2016-11-14
Accepted
2016-11-14 14:14:24
Documents
66
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20160901_10q.htm 10-Q 788570
2 EXHIBIT 3.1 ex3-1.htm EX-3.1 35003
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 10123
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 10629
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6138
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 6586
13 diffusion.jpg GRAPHIC 36540
  Complete submission text file 0001437749-16-042010.txt   4618851

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS dffn-20160930.xml EX-101.INS 734456
8 EXHIBIT 101.SCH dffn-20160930.xsd EX-101.SCH 57351
9 EXHIBIT 101.CAL dffn-20160930_cal.xml EX-101.CAL 27090
10 EXHIBIT 101.DEF dffn-20160930_def.xml EX-101.DEF 428579
11 EXHIBIT 101.LAB dffn-20160930_lab.xml EX-101.LAB 332580
12 EXHIBIT 101.PRE dffn-20160930_pre.xml EX-101.PRE 438649
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 161993586
SIC: 2834 Pharmaceutical Preparations